Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly K Bree

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
JAMA Network Open|March 18, 2022
Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013Kelly K Bree, Yong Shan, Patrick J Hensley, et al.
BJU International|April 29, 2024
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare systemKelly K Bree, Jessica L Janes, Patrick J Hensley, et al.
Urologic Oncology|December 11, 2025
Disparities and temporal trends in referral for bladder cancer diagnosis: A worsening epidemicAmanda A Myers, Zhigang Duan, Daniel A Igel, et al.
European Urology|June 15, 2024
Challenging the Paradigm of "BCG-unresponsive" Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?Amanda A Myers, Wei Shen Tan, Valentina Grajales, et al.
European Urology Oncology|October 24, 2024
Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated AnalysisNiyati Lobo, Zhigang Duan, Akshay Sood, et al.
The Journal of Urology|October 17, 2022
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|May 22, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. ReplyKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|September 9, 2022
Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement StudyMary E Westerman, Kelly K Bree, Pavlos Msaouel, et al.
BJU International|March 30, 2021
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic responsePatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
The Journal of Urology|June 30, 2022
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta TumorsKelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
JAMA Network Open|March 18, 2022
Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013Kelly K Bree, Yong Shan, Patrick J Hensley, et al.
BJU International|April 29, 2024
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare systemKelly K Bree, Jessica L Janes, Patrick J Hensley, et al.
Urologic Oncology|December 11, 2025
Disparities and temporal trends in referral for bladder cancer diagnosis: A worsening epidemicAmanda A Myers, Zhigang Duan, Daniel A Igel, et al.
European Urology|June 15, 2024
Challenging the Paradigm of "BCG-unresponsive" Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?Amanda A Myers, Wei Shen Tan, Valentina Grajales, et al.
European Urology Oncology|October 24, 2024
Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated AnalysisNiyati Lobo, Zhigang Duan, Akshay Sood, et al.
The Journal of Urology|October 17, 2022
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|May 22, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. ReplyKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|September 9, 2022
Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement StudyMary E Westerman, Kelly K Bree, Pavlos Msaouel, et al.
BJU International|March 30, 2021
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic responsePatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
The Journal of Urology|June 30, 2022
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta TumorsKelly K Bree, Patrick J Hensley, Niyati Lobo, et al.
Pageof 5